Fiche publication


Date publication

avril 2021

Journal

European journal of neurology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis


Tous les auteurs :
Mathey G, Ancel T, Garot T, Soudant M, Pittion-Vouyovitch S, Guillemin F, Debouverie M, Epstein J

Résumé

Patients with secondary progressive multiple sclerosis (SP MS) and clinical and/or radiological activity could be the more likely to benefit from disease modifying treatments. To evaluate the proportions each year after progression onset, we studied patients with SP MS onset between 2002 and 2012 from a population-based multiple sclerosis registry in North-Eastern France.

Mots clés

1. Multiple Sclerosis, 2. Secondary progression, 3. Activity, 4. Magnetic Resonance Imaging, 5. Epidemiology

Référence

Eur J Neurol. 2021 Apr 10;: